Catalyst Wire Dossier Catalyst Wire Dossier

APD403

APD403 · Acacia Pharma Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APD403, covering 2019-03-12 to 2019-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy [Phase 2]

See pricing